Journal of Molecular Medicine

SJR Rank #2,759H-index: 167SJR: 1.401Best quartile: Q1APC: US$4,390
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Drug DiscoveryQ1
  • Genetics (clinical)Q1
  • Molecular MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Biomedical and Chemical ResearchMedical and Health Sciences ResearchPsychology, Coaching, and TherapyEuropean history and politicsSports Science and EducationHealth and Medical StudiesMetabolism and Genetic DisordersMedical History and ResearchDiet and metabolism studiesErythrocyte Function and Pathophysiology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

2022202503570105140

Detailed Information

ISSN

0946-2716, 1432-1440

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.85

References per Document

70.17

Coverage

1976-1978, 1980-1981, 1995-2026

Scope

The Journal of Molecular Medicine publishes original research articles and review articles that range from basic findings in mechanisms of disease pathogenesis to therapy. The focus includes all human diseases, including but not limited to: Aging, angiogenesis, autoimmune diseases as well as other inflammatory diseases, cancer, cardiovascular diseases, development and differentiation, endocrinology, gastrointestinal diseases and hepatology, genetics and epigenetics, hematology, hypoxia research, immunology, infectious diseases, metabolic disorders, neuroscience of diseases, -omics based disease research, regenerative medicine, and stem cell research. Studies solely based on cell lines will not be considered. Studies that are based on model organisms will be considered as long as they are directly relevant to human disease.

Metrics from SCImago Journal Rank 2025. View on SCImago